Item 1(a). | Name of Issuer: |
Establishment Labs Holdings Inc. (the “Issuer”)
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
Building B15 and 25, Coyol Free Zone, Alajuala, Costa Rica
Item 2(a). | Names of Persons Filing: |
The names of the persons filing this report (collectively, the “Reporting Persons”) are:
Perceptive Advisors LLC (“Perceptive Advisors”)
Joseph Edelman (“Mr. Edelman”)
Perceptive Life Sciences Master Fund, Ltd. (the “Master Fund”)
Item 2(b). | Address of Principal Business Office or, if None, Residence: |
The address of the principal business office of each of the Reporting Persons is:
51 Astor Place, 10th Floor
New York, NY 10003
Perceptive Advisors is a Delaware limited liability company
Mr. Edelman is a United States citizen
The Master Fund is a Cayman Islands corporation
Item 2(d). | Title of Class of Securities: |
Common Shares (“Common Stock”)
G31249 108
Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or240.13d-2(b) or (c), check whether the person filing is a: |
Not applicable.
The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover page to this Schedule 13G. The ownership percentages reported are based on 22,860,783 outstanding shares of Common Stock, as reported in the Issuer’s prospectus supplement filed on January 30, 2020.
The shares reported on the cover pages to this Schedule 13G are held directly by the Master Fund. Perceptive Advisors serves as the investment manager to the Master Fund and may be